Oncology - European Medical Journal

Continue

Oncology

Filter
8 Mins
6 Dec 2018

Prediction with Precision: Does TAILORx Make Chemotherapy a Personalised Treatment?

Adjuvant chemotherapy (CT) is commonly recommended to breast cancer patients following surgery. However, not all patients benefit from it, and the…
10 Mins
6 Dec 2018

Genomic Profiling Clinical Trials in Cancer of Unknown Primary

Cancer of unknown primary (CUP) accounts for 3–5% of all cancers, and prognosis is poor for most patients, with a median survival of 6–9 months…
13 Mins
6 Dec 2018

Editor's Pick: Novel Targets and Therapies in T Cell Lymphoma

This review presents the recent advances in our understanding of the cellular pathogenesis of T cell non-Hodgkin lymphoma (NHL) and the potential of…
12 Mins
6 Dec 2018

Recent Advances in the Treatment of Metastatic Soft Tissue Sarcoma

Soft tissue sarcomas (STS) are a rare group of heterogeneous malignancies with >50 histologic subtypes that have varying biological behaviour and…
8 Mins
6 Dec 2018

Clinical Issues for Prostate-Specific Antigen Screening: A Narrative Review

Prostate cancer, with its remarkably high prevalence, frequently creates clinical problems in terms of screening and diagnosis, as well as identifying…
11 Mins
6 Dec 2018

Mantle Cell Lymphoma: Are New Therapies Changing the Standard of Care?

The prognosis of mantle cell lymphoma (MCL) has improved rapidly over recent years with the evolution of new management strategies. The disease, once…
14 Mins
3 Dec 2018

Realising the Full Potential of Biosimilars: Interviews with Three Key Opinion Leaders

These valuable insights were obtained from a series of interviews conducted between 19th September and 8th October 2018 by the European Medical Journal…
14 Mins
4 Oct 2018

The Role of PARP Inhibitors in Ovarian Cancer: An Emerging Picture

Dr Birrer presented on the current landscape of platinum-sensitive recurrent ovarian cancer (PSR OC), including USA and European treatment guidelines.